Cargando…
Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD
BACKGROUND: The burden of symptoms varies markedly between patients with COPD and is only weakly correlated with lung function impairment. While heterogeneity in lung function decline and exacerbations have been previously studied, the extent of heterogeneity in symptoms and the factors associated w...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296193/ https://www.ncbi.nlm.nih.gov/pubmed/30587954 http://dx.doi.org/10.2147/COPD.S184424 |
_version_ | 1783381001946267648 |
---|---|
author | Johnson, Kate M Safari, Abdollah Tan, Wan C Bourbeau, Jean FitzGerald, J Mark Sadatsafavi, Mohsen study, On behalf of the Canadian Cohort of Obstructive Lung Disease (CanCOLD) |
author_facet | Johnson, Kate M Safari, Abdollah Tan, Wan C Bourbeau, Jean FitzGerald, J Mark Sadatsafavi, Mohsen study, On behalf of the Canadian Cohort of Obstructive Lung Disease (CanCOLD) |
author_sort | Johnson, Kate M |
collection | PubMed |
description | BACKGROUND: The burden of symptoms varies markedly between patients with COPD and is only weakly correlated with lung function impairment. While heterogeneity in lung function decline and exacerbations have been previously studied, the extent of heterogeneity in symptoms and the factors associated with this heterogeneity are not well understood. METHODS: A sample of the general Canadian population ≥40 years with persistent airflow limitation was followed for up to 3 years. Participants reported whether they experienced chronic coughing, phlegm, wheezing, or dyspnea during visits at 18-month intervals. We used mixed-effect logistic regression models (separately for each symptom) to assess overall heterogeneity in the occurrence of symptoms between individuals, and the proportion of variation in symptom burden explained by lung function vs all other clinical characteristics of participants. RESULTS: Four hundred forty-nine participants (53% male, mean age 67 years) contributed 968 visits in total, and 89% of patients reported at least one symptom during follow-up. There was substantial heterogeneity in the individual-specific probabilities for the occurrence of symptoms. This heterogeneity was highest for wheeze and dyspnea (IQR of probabilities: 0.13–0.78 and 0.19–0.81, respectively). FEV(1) explained 28% of the variation between individuals in the occurrence of dyspnea, 8% for phlegm, 3% for cough, and 2% for wheeze. All clinical characteristics of participants (including FEV(1)) explained between 26% of heterogeneity in the occurrence of cough to 49% for dyspnea. CONCLUSION: There is marked heterogeneity in the burden of respiratory symptoms between COPD patients. The ability of lung function and other commonly measured clinical characteristics to explain this heterogeneity differs between symptoms. |
format | Online Article Text |
id | pubmed-6296193 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62961932018-12-26 Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD Johnson, Kate M Safari, Abdollah Tan, Wan C Bourbeau, Jean FitzGerald, J Mark Sadatsafavi, Mohsen study, On behalf of the Canadian Cohort of Obstructive Lung Disease (CanCOLD) Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: The burden of symptoms varies markedly between patients with COPD and is only weakly correlated with lung function impairment. While heterogeneity in lung function decline and exacerbations have been previously studied, the extent of heterogeneity in symptoms and the factors associated with this heterogeneity are not well understood. METHODS: A sample of the general Canadian population ≥40 years with persistent airflow limitation was followed for up to 3 years. Participants reported whether they experienced chronic coughing, phlegm, wheezing, or dyspnea during visits at 18-month intervals. We used mixed-effect logistic regression models (separately for each symptom) to assess overall heterogeneity in the occurrence of symptoms between individuals, and the proportion of variation in symptom burden explained by lung function vs all other clinical characteristics of participants. RESULTS: Four hundred forty-nine participants (53% male, mean age 67 years) contributed 968 visits in total, and 89% of patients reported at least one symptom during follow-up. There was substantial heterogeneity in the individual-specific probabilities for the occurrence of symptoms. This heterogeneity was highest for wheeze and dyspnea (IQR of probabilities: 0.13–0.78 and 0.19–0.81, respectively). FEV(1) explained 28% of the variation between individuals in the occurrence of dyspnea, 8% for phlegm, 3% for cough, and 2% for wheeze. All clinical characteristics of participants (including FEV(1)) explained between 26% of heterogeneity in the occurrence of cough to 49% for dyspnea. CONCLUSION: There is marked heterogeneity in the burden of respiratory symptoms between COPD patients. The ability of lung function and other commonly measured clinical characteristics to explain this heterogeneity differs between symptoms. Dove Medical Press 2018-12-13 /pmc/articles/PMC6296193/ /pubmed/30587954 http://dx.doi.org/10.2147/COPD.S184424 Text en © 2018 Johnson et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Johnson, Kate M Safari, Abdollah Tan, Wan C Bourbeau, Jean FitzGerald, J Mark Sadatsafavi, Mohsen study, On behalf of the Canadian Cohort of Obstructive Lung Disease (CanCOLD) Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD |
title | Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD |
title_full | Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD |
title_fullStr | Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD |
title_full_unstemmed | Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD |
title_short | Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD |
title_sort | heterogeneity in the respiratory symptoms of patients with mild-to-moderate copd |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296193/ https://www.ncbi.nlm.nih.gov/pubmed/30587954 http://dx.doi.org/10.2147/COPD.S184424 |
work_keys_str_mv | AT johnsonkatem heterogeneityintherespiratorysymptomsofpatientswithmildtomoderatecopd AT safariabdollah heterogeneityintherespiratorysymptomsofpatientswithmildtomoderatecopd AT tanwanc heterogeneityintherespiratorysymptomsofpatientswithmildtomoderatecopd AT bourbeaujean heterogeneityintherespiratorysymptomsofpatientswithmildtomoderatecopd AT fitzgeraldjmark heterogeneityintherespiratorysymptomsofpatientswithmildtomoderatecopd AT sadatsafavimohsen heterogeneityintherespiratorysymptomsofpatientswithmildtomoderatecopd AT studyonbehalfofthecanadiancohortofobstructivelungdiseasecancold heterogeneityintherespiratorysymptomsofpatientswithmildtomoderatecopd AT heterogeneityintherespiratorysymptomsofpatientswithmildtomoderatecopd |